Insider Stock Trading History of Mehra Anand


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Mehra Anand since year 2005. The trader's CIK number is 1590102. At the time of this reporting, Mehra Anand is the of Spark Therapeutics, Inc. . (stock ticker symbol ONCE). See this page for all insider trading activities at Spark Therapeutics, Inc. .

Note that in the past Mehra Anand also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Mehra Anand since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-07-24 ONCE Spark Therapeutics, Inc. Sale 211,858 71.75 15,201,447
2017-06-20 ONCE Spark Therapeutics, Inc. Sale 1,020 65.00 66,300
2017-06-21 ONCE Spark Therapeutics, Inc. Sale 5,282 65.00 343,330
2017-03-02 ONCE Spark Therapeutics, Inc. Sale 15,275 65.01 993,027
2017-03-01 ONCE Spark Therapeutics, Inc. Sale 17,470 65.01 1,135,724
2017-02-28 ONCE Spark Therapeutics, Inc. Sale 25,274 65.02 1,643,315
2017-02-27 ONCE Spark Therapeutics, Inc. Sale 41,910 65.02 2,724,988
2017-02-17 ONCE Spark Therapeutics, Inc. Sale 7,535 65.01 489,850
2017-02-14 ONCE Spark Therapeutics, Inc. Sale 950 65.02 61,768
2017-02-15 ONCE Spark Therapeutics, Inc. Sale 31,497 65.03 2,048,249
2017-02-16 ONCE Spark Therapeutics, Inc. Sale 2,900 65.01 188,529
2017-02-09 ONCE Spark Therapeutics, Inc. Sale 37,411 65.06 2,433,959
2017-02-03 ONCE Spark Therapeutics, Inc. Sale 22,330 65.06 1,452,789
2017-02-06 ONCE Spark Therapeutics, Inc. Sale 1,010 65.00 65,650
2017-02-07 ONCE Spark Therapeutics, Inc. Sale 1,994 65.04 129,689
2017-01-10 ACRS Aclaris Therapeutics, Inc. Sale 750,000 28.25 21,188,250
2016-12-15 ONCE Spark Therapeutics, Inc. Sale 69,928 53.07 3,711,078
2016-12-16 ONCE Spark Therapeutics, Inc. Sale 279,728 54.09 15,129,088
2016-12-09 ONCE Spark Therapeutics, Inc. Sale 100,251 55.23 5,537,063
2016-12-13 ONCE Spark Therapeutics, Inc. Sale 22,281 53.32 1,188,022
2016-08-11 ONCE Spark Therapeutics, Inc. Sale 23,063 60.81 1,402,461
2016-08-10 ONCE Spark Therapeutics, Inc. Sale 6,900 60.02 414,138
2016-08-08 ONCE Spark Therapeutics, Inc. Sale 100 60.47 6,047
2016-08-03 ONCE Spark Therapeutics, Inc. Sale 4,612 60.00 276,720
2016-08-04 ONCE Spark Therapeutics, Inc. Sale 452 60.00 27,120
2016-08-01 ONCE Spark Therapeutics, Inc. Sale 22,665 60.03 1,360,579
2016-05-31 ONCE Spark Therapeutics, Inc. Sale 500 60.00 30,000
2015-11-25 ONCE Spark Therapeutics, Inc. Sale 17,611 60.01 1,056,836
2015-11-27 ONCE Spark Therapeutics, Inc. Sale 5,350 60.02 321,107
2015-11-12 ONCE Spark Therapeutics, Inc. Sale 1,074 60.00 64,440
2015-11-09 ONCE Spark Therapeutics, Inc. Sale 25,955 60.07 1,559,116
2015-11-10 ONCE Spark Therapeutics, Inc. Sale 5,932 60.01 355,979
2015-11-11 ONCE Spark Therapeutics, Inc. Sale 97,644 60.13 5,871,333
2015-10-13 ACRS Aclaris Therapeutics, Inc. Buy 409,090 11.00 4,499,990
2015-10-07 ONCE Spark Therapeutics, Inc. Sale 251,912 46.31 11,666,044
2015-10-08 ONCE Spark Therapeutics, Inc. Sale 277,632 45.34 12,588,667
2015-10-06 MIRN Mirna Therapeutics, Inc. Buy 857,142 7.00 5,999,994
2015-05-12 LIFE Atyr Pharma Inc Buy 320,000 14.00 4,480,000
2015-04-14 AERI Aerie Pharmaceuticals Inc Sale 130,702 34.08 4,453,932
2015-04-15 AERI Aerie Pharmaceuticals Inc Sale 294,298 33.45 9,843,973
2015-02-04 ONCE Spark Therapeutics, Inc. Buy 225,000 23.00 5,175,000
2014-12-08 HSGX Histogenics Corp Buy 500,198 11.00 5,502,178
2014-12-08 HSGX Histogenics Corp Sale 1,002 11.00 11,022
2014-11-25 AERI Aerie Pharmaceuticals Inc Sale 800,000 26.00 20,800,000
2014-07-09 AERI Aerie Pharmaceuticals Inc Sale 1,000,000 24.00 24,001,000
2014-07-10 AERI Aerie Pharmaceuticals Inc Sale 8,022 25.81 207,031

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mehra Anand ( of Spark Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.